Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Adverum Biotechnologies, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 68
- +7 vs. Q1 2024
- Shares held
- 17.9M
- +1.11M (+6.6%) vs. Q1 2024
- Total value
- $117.7M
- −$119.2M (−50.3%) vs. Q1 2024
- New holders
- 20
- 24 more added
- Sold out
- 13
- 13 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lazard Asset Management LLC | 46 | $0 | 0.00% | −654−93.4% | Reduced |
| Frazier Financial Advisors, LLC | 1 | $7 | 0.00% | +1 | New |
| Deutsche Bank AG | 2 | $14 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 2 | $17 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 19 | $130 | 0.00% | −9,231−99.8% | Reduced |
| GHP Investment Advisors, Inc. | 20 | $138 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 50 | $343 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 322 | $2.00K | 0.00% | +322 | New |
| Amalgamated Bank | 720 | $5.00K | 0.00% | +720 | New |
| Tower Research Capital LLC (TRC) | 1,461 | $10.0K | 0.00% | +458+45.7% | Added |
| BNP Paribas Arbitrage, SA | 1,497 | $10.3K | 0.00% | +1,497 | New |
| California State Teachers Retirement System | 1,507 | $10.3K | 0.00% | +1,507 | New |
| Legal & General Group Plc | 1,797 | $12.3K | 0.00% | +1,797 | New |
| Ameritas Investment Partners, Inc. | 2,038 | $14.0K | 0.00% | +2,038 | New |
| Royal Bank of Canada | 2,234 | $15.0K | 0.00% | +2,223+20,209.1% | Added |
| Northwest & Ethical Investments L.P. | 3,390 | $23.3K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 4,669 | $32.0K | 0.00% | −47,936−91.1% | Reduced |
| MetLife Investment Management | 5,493 | $37.7K | 0.00% | +5,493 | New |
| UBS Group AG | 6,358 | $43.6K | 0.00% | +5,426+582.2% | Added |
| Advisor Group Holdings, Inc. | 8,574 | $58.8K | 0.00% | +6,524+318.2% | Added |
| JPMorgan Chase & Co | 8,904 | $61.1K | 0.00% | +8,866+23,331.6% | Added |
| Wells Fargo & Company | 9,140 | $62.7K | 0.00% | +8,998+6,336.6% | Added |
| Bayesian Capital Management, LP | 10,756 | $73.8K | 0.01% | +10,756 | New |
| Corebridge Financial, Inc. | 11,192 | $76.9K | 0.00% | +11,192 | New |
| ADAR1 Capital Management, LLC | 11,300 | $77.5K | 0.02% | +8,500+303.6% | Added |
| Graham Capital Management, L.P. | 11,782 | $80.8K | 0.00% | +11,782 | New |
| New York State Common Retirement Fund | 14,400 | $98.8K | 0.00% | +14,400 | New |
| Cantor Fitzgerald, L. P. | 15,446 | $106.0K | 0.02% | 00.0% | Unchanged |
| Barclays PLC | 15,867 | $108.8K | 0.00% | −37,391−70.2% | Reduced |
| Qube Research & Technologies Ltd | 16,265 | $111.6K | 0.00% | −25,354−60.9% | Reduced |
| Bank of Montreal | 16,242 | $129.9K | 0.00% | +16,242 | New |
| Two Sigma Advisers, LP | 22,901 | $157.1K | 0.00% | +6,731+41.6% | Added |
| Jump Financial, LLC | 24,203 | $166.0K | 0.00% | +24,203 | New |
| Quinn Opportunity Partners LLC | 26,829 | $184.0K | 0.02% | 00.0% | Unchanged |
| Jane Street Group, LLC | 29,202 | $200.3K | 0.00% | +29,202 | New |
| Rhumbline Advisers | 30,821 | $211.4K | 0.00% | +30,528+10,419.1% | Added |
| Northern Trust Corp | 47,163 | $323.5K | 0.00% | +10,423+28.4% | Added |
| Charles Schwab Investment Management Inc | 59,734 | $409.8K | 0.00% | +49,021+457.6% | Added |
| Bank of New York Mellon Corp | 64,585 | $443.1K | 0.00% | +64,585 | New |
| Nuveen Asset Management, LLC | 68,537 | $470.2K | 0.00% | +68,537 | New |
| Millennium Management LLC | 69,411 | $476.2K | 0.00% | −179,231−72.1% | Reduced |
| Two Sigma Investments, LP | 77,345 | $530.6K | 0.00% | +65,503+553.1% | Added |
| Squarepoint Ops LLC | 108,978 | $747.6K | 0.00% | +81,808+301.1% | Added |
| Vivo Capital, LLC | 833,333 | $833.3K | 0.08% | −666,667−44.4% | Reduced |
| Picton Mahoney Asset Management | 123,743 | $850.0K | 0.04% | −223−0.2% | Reduced |
| Citadel Advisors LLC | 125,790 | $862.9K | 0.00% | +125,790 | New |
| Morgan Stanley | 129,259 | $886.7K | 0.00% | −432,776−77.0% | Reduced |
| Renaissance Technologies LLC | 136,257 | $934.7K | 0.00% | +3,169+2.4% | Added |
| Soleus Capital Management, L.P. | 147,246 | $1.01M | 0.09% | +147,246 | New |
| Bank of America Corp | 176,099 | $1.21M | 0.00% | +10,604+6.4% | Added |
| Marshall Wace, LLP | 204,619 | $1.40M | 0.00% | +70,768+52.9% | Added |
| Dimensional Fund Advisors LP | 223,427 | $1.53M | 0.00% | +196,884+741.8% | Added |
| State Street Corp | 278,504 | $1.91M | 0.00% | +213,780+330.3% | Added |
| Goldman Sachs Group Inc | 396,931 | $2.72M | 0.00% | +396,931 | New |
| Logos Global Management LP | 416,666 | $2.86M | 0.33% | −1,083,333−72.2% | Reduced |
| Avoro Capital Advisors LLC | 416,666 | $2.86M | 0.04% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 455,787 | $3.13M | 0.00% | +262,271+135.5% | Added |
| Versant Venture Management, LLC | 506,821 | $3.48M | 4.50% | −10.0% | Reduced |
| 5AM Venture Management, LLC | 541,666 | $3.72M | 0.83% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 617,910 | $4.24M | 0.01% | +259,191+72.3% | Added |
| FMR LLC | 637,509 | $4.37M | 0.00% | −263,018−29.2% | Reduced |
| Vanguard Group Inc | 1,009,459 | $6.92M | 0.00% | +102,308+11.3% | Added |
| Frazier Life Sciences Management, L.P. | 1,069,244 | $7.34M | 0.34% | 00.0% | Unchanged |
| BlackRock Inc. | 1,409,441 | $9.67M | 0.00% | +1,092,991+345.4% | Added |
| VR Adviser, LLC | 1,467,048 | $10.1M | 0.64% | −89,371−5.7% | Reduced |
| Franklin Resources Inc | 1,760,052 | $12.1M | 0.00% | +1,084,377+160.5% | Added |
| BML Capital Management, LLC | 1,966,000 | $13.5M | 9.88% | +1,132,883+136.0% | Added |
| TCG Crossover Management, LLC | 2,008,340 | $13.8M | 1.44% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −657,333−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −438,935−100.0% | Sold out |
| Samsara BioCapital, LLC | 0 | $0 | 0.00% | −291,666−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −162,547−100.0% | Sold out |
| Newtyn Management, LLC | 0 | $0 | 0.00% | −46,189−100.0% | Sold out |
| Marathon Trading Investment Management LLC | 0 | $0 | 0.00% | −28,340−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −23,395−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −16,369−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,198−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −9,276−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −8,483−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −2,902−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −2,586−100.0% | Sold out |